Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Abstract
The ruthenium complex salt indazolium trans-[tetrachlorobisindazole-ruthenate(III)] (KP1019) and the analogous sodium salt KP1339 are effective tumor-inhibiting drugs in experimental therapy of autochthonous colorectal carcinomas in rats. This paper examines the cell biological mechanisms underlying their antineoplastic effects.

This publication has 27 references indexed in Scilit: